Agenzia Italiana del Farmaco
Direct communication with healthcare professionals on Donepezil containing medicinal products - Direct communication with healthcare professionals on Donepezil containing medicinal products
Direct communication with healthcare professionals on Donepezil containing medicinal products

Donepezil containing medicinal products: Addition to the product safety information regarding cardiac conductions disorders including QT prolongation and Torsade de Pointes.
Summary
- There have been post-marketing reports of QTc interval prolongation and Torsade de Pointes in association with donepezil therapy
- Caution is advised in patients with pre-existing or family history of QTc prolongation
- Caution is advised in patients with concomitant treatment with medicinal products that affect the QTc interval or induce bradycardia
- Caution is advised in patients with relevant heart disease or electrolyte disturbances. At risk patients should be considered for monitoring with electrocardiograms (ECG).
- Addition of undesirable effects: Polymorphic ventricular tachycardia including Torsade de Pointes, Electrocardiogram QT interval prolonged
- Update of Drug interactions
Published on: 07 February 2022
Una legislazione farmaceutica moderna è fondamentale per accompagnare l'#innovazione e garantire ai ...
Vai al post →
Si conclude la campagna #MedSafetyWeek di quest’anno! 🎉
Grazie per aver seguito i nostri canali in...
Vai al post →
Se sei un professionista sanitario, cogli l’occasione per discutere e individuare gli effetti indesi...
Vai al post →
💬 Ti è mai capitato di pensare “è solo un’eruzione cutanea”, “sono soltanto stressato” o “probabilm...
Vai al post →
Esistono diversi tipi di effetti indesiderati dei #farmaci: il modo in cui si manifestano può dipend...
Vai al post →
📍 A Roma la seconda edizione del Policy & Business Forum del Gruppo Editoriale @urania.news, import...
Vai al post →
